{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.528(a) aphrodisiac Korean ginseng
Source URL:
First approved in 2000
Source:
M017
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Bio NO more Joint Pain (Helps improve osteoarthritis and immunity, Soybean fermented powder and Oplopanax elatus nakai extract powder) by HumanEnos LLC
(2024)
Source URL:
First approved in 2024
Source:
Bio NO more Joint Pain (Helps improve osteoarthritis and immunity, Soybean fermented powder and Oplopanax elatus nakai extract powder) by HumanEnos LLC
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
CHOpro by sanPharma GmbH
(2018)
Source URL:
First approved in 2018
Source:
CHOpro by sanPharma GmbH
Source URL:
Class:
STRUCTURALLY DIVERSE